Article Details
Retrieved on: 2021-12-21 14:15:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
BioAtla, Inc., a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here